Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001244008.2(KIF1A):c.173C>T(p.Ser58Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S58W) has been classified as Likely pathogenic.
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
Verdict is Pathogenic. Variant got 17 ACMG points.
PM2
?
PM2 - Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium
Very rare variant in population databases, with high coverage;
PM5
?
PM5 - Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before
Other missense variant is known to change same aminoacid residue: Variant chr2-240789246-G-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1349128.Status of the report is criteria_provided_single_submitter, 1 stars.
PP2
?
PP2 - Missense variant in a gene that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease
Missense variant where missense usually causes diseases, KIF1A
PP3
?
PP3 - Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc.)
MetaRNN computational evidence supports a deleterious effect, 0.981
PP5
?
PP5 - Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation
Variant 2-240789246-G-A is Pathogenic according to our data. Variant chr2-240789246-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 162052.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-240789246-G-A is described in Lovd as [Pathogenic].
CHU Sainte-Justine Research Center, University of Montreal
Jan 01, 2014
- -
Pathogenic, no assertion criteria provided
clinical testing
Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals
Aug 28, 2017
- -
Pathogenic, criteria provided, single submitter
clinical testing
Genetic Services Laboratory, University of Chicago
Mar 10, 2016
- -
Hereditary spastic paraplegia 30 Pathogenic:2
Pathogenic, criteria provided, single submitter
clinical testing
Mendelics
May 28, 2019
- -
Pathogenic, criteria provided, single submitter
clinical testing
Paris Brain Institute, Inserm - ICM
-
- -
Neurodevelopmental delay Pathogenic:1
Pathogenic, criteria provided, single submitter
clinical testing
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
-
- -
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Ambry Genetics
Apr 13, 2018
- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter
clinical testing
GeneDx
Jul 07, 2022
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28332297, 27146152, 34487232, 28333917, 29915382, 25265257, 31455732, 30612907, 26125038, 21820098, 21376300, 33880452) -
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) with autosomal dominant complicated hereditary spastic paraplegia (PMID: 25265257, 27146152, 28333917, 29915382). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 162052). This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with leucine at codon 58 of the KIF1A protein (p.Ser58Leu). The serine residue is highly conserved and there is a large physicochemical difference between serine and leucine. -
Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);Loss of disorder (P = 0.0106);